Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

Stopped early

Conditions studied: Castration-Resistant Prostate Cancer

In brief

The primary purpose of this research is to describe patient characteristics predictive of an imaging study positive for distant metastases in patients with castration-resistant prostate cancer and no known distant metastases.

Key facts

Study ID

NCT01981109

Run by

Dendreon

People needed

225

Starts

2012-01-01

Expected to finish

2017-07-01

Last updated by the study team

2019-08-28

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Written informed consent obtained prior to the initiation of study procedures.
• Men ≥ 18 years of age.
• Histologically documented prostatic adenocarcinoma.
• History of Castration-Resistant Prostate Cancer.

You may not qualify if…

• Known M1 disease.
• Undergone imaging study for metastatic prostate cancer ≤ 3 months.
• ECOG performance status ≥ 3.
• Known malignant pleural effusions or ascites.
• Current or prior treatment with investigational therapy for M0 Castration-Resistant Prostate Cancer (Taxotere (docetaxel), Provenge® (sipuleucel-T), Zytiga (abiraterone acetate), Xtandi (enzalutamide), Jevtana (cabazitaxel), or Xofigo (radium Ra 223 dichloride).

Where it is running

• Urological Associate of Southern Arizona — Tucson, Arizona, United States
• Sequoia Urology Center — Atherton, California, United States
• Prostate Oncology Specialist, Inc. — Marina del Rey, California, United States
• Sutter Medical Group — Sacramento, California, United States
• Genesis Research — San Diego, California, United States
• Urology Associates of San Luis Obispo — Templeton, California, United States
• The Urology Center of Colorado — Denver, Colorado, United States
• Advanced Urology, P.C — Parker, Colorado, United States
• Howard University Hospital — Washington D.C., District of Columbia, United States
• Urology Center of South Florida — Miami, Florida, United States
• Idaho Urologic Institute — Meridian, Idaho, United States
• Comprehensive Urologic Care, SC — Lake Barrington, Illinois, United States
• Uro Partners/ RMD Clinical Research — Melrose Park, Illinois, United States
• Associated Urological Specialists, LLC — Palos Heights, Illinois, United States
• 1st Urology, PSC — Jeffersonville, Indiana, United States
• Northern Indiana Cancer Research Consortium — South Bend, Indiana, United States
• Kansas City Urology Care, PA — Overland Park, Kansas, United States
• Cancer Center of Kansas — Wichita, Kansas, United States
• Jewish Hospital — Louisville, Kentucky, United States
• Tulane University — New Orleans, Louisiana, United States
• Highland Clinic — Shreveport, Louisiana, United States
• Regional Urology, LLC — Shreveport, Louisiana, United States
• Mid Atlantic Urology Associates — Greenbelt, Maryland, United States
• Chesapeake Urology Research Associates — Towson, Maryland, United States
• Alaska Clinical Research Center, LLC — Anchorage, Alaska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.